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Abstract
Purpose: The treatment of stroke remains a challenge. Animal studies showing that electrical stimulation of the
sphenopalatine ganglion (SPG) exerts beneficial effects in the treatment of stroke have led to the initiation of clinical
studies. However, the detailed effects of SPG stimulation on the injured brain are not known.
Methods: The effect of acute SPG stimulation was studied by direct vascular imaging, fluorescent angiography and laser
Doppler flowmetry in the sensory motor cortex of the anaesthetized rat. Focal cerebral ischemia was induced by the rose
bengal (RB) photothrombosis method. In chronic experiments, SPG stimulation, starting 15 min or 24 h after
photothrombosis, was given for 3 h per day on four consecutive days. Structural damage was assessed using histological
and immunohistochemical methods. Cortical functions were assessed by quantitative analysis of epidural electro-
corticographic (ECoG) activity continuously recorded in behaving animals.
Results: Stimulation induced intensity- and duration-dependent vasodilation and increased cerebral blood flow in both
healthy and photothrombotic brains. In SPG-stimulated rats both blood brain-barrier (BBB) opening, pathological brain
activity and lesion volume were attenuated compared to untreated stroke animals, with no apparent difference in the glial
response surrounding the necrotic lesion.
Conclusion: SPG-stimulation in rats induces vasodilation of cortical arterioles, partial reperfusion of the ischemic lesion, and
normalization of brain functions with reduced BBB dysfunction and stroke volume. These findings support the potential
therapeutic effect of SPG stimulation in focal cerebral ischemia even when applied 24 h after stroke onset and thus may
extend the therapeutic window of currently administered stroke medications.
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Introduction
In cerebral stroke – a leading cause of morbidity and mortality
in the aged population – the ischemic brain is typically
characterized by a central core with very low perfusion which
undergoes necrotic cell death, and a surrounding dysfunctional
peri-ischemic region, also often known as the ‘stroke penumbra’
[1]. Neuronal dysfunction in the peri-ischemic region appears to
arise from several interrelated processes including reduced energy
supply, metabolic and ionic disturbances, vascular compromise,
blood-brain barrier (BBB) dysfunction, glial and immunological
response [2,3]. It is the fate of the peri-ischemic region that often
determines the extent of the patient’s recovery. Importantly, stroke
may progress or become hemorrhagic and the penumbra may
become part of the necrotic region. Furthermore, even if the peri-
ischemic region does escape cell death, recovery may not be
complete and this zone may become dysfunctional, epileptic or
undergo delayed neurodegeneration.
To this end, available treatments in stroke focus on improving
brain tissue perfusion. Targeting vascular injury/BBB dysfunction
or immune response within the peri-ischemic region is not yet a
treatment option (however see [4]). Thus, intravenous recombi-
nant tissue plasminogen activator (IV r-tPA) and mechanical
recanalization remain the only approved treatments for stroke.
The fundamental limitation of these therapies is the short
treatment window (4–5 h from stroke onset for IV r-tPA and
,8 h for the use of the recanalization devices [5]). Moreover,
symptomatic hemorrhagic transformation of the infarct associated
with the administration of IV r-tPA remains a primary concern
[6]. In the USA, for example, only about 4% of ischemic stroke
patients are treated with IV r-tPA [7]. Hence, there is substantial
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cerebral ischemia.
A possible treatment route that is currently being studied is
stimulation of the sphenopalatine ganglion (SPG) ((http://
clinicaltrials.gov/ct2/show/
NCT00826059?term=Brainsgate&rank=1), [8]). The SPG is the
source of parasympathetic innervations to the anterior cerebral
circulation,whichcomprisesthemiddlecerebralartery,theanterior
cerebral artery, and their tributaries. Studies in rodents, dogs and
monkeyshavedemonstratedthatstimulatingneuronswithintheSPG
after permanent middle cerebral artery occlusion (MCAO) leads to
an ipsilateral increase in regional cerebral blood flow (rCBF) [9–13]
and, at high stimulation intensities, to BBB breakdown [14]. In a
magnetic resonance imaging (MRI) study in rats, Henninger and
Fisher (2007) [15] reported that a single train (four sets) of SPG
stimulation,15minutesafterMCAOledtoelevatedrCBFintheperi-
ischemic region and to a significantly reduced infarct volume 24 h
after treatment. In accordance, a recent study has shown that
resection of the SPG leads to an increased infarct volume following
MCAO [16].
The aims of the present study were to use imaging methods to
test directly the effect of SPG stimulation on vascular diameter and
permeability, rCBF, infarct size and neuronal network activity in
the acutely ischemic cortex. A better insight into the mechanisms
underlying the effects of SPG may improve patient selection and
follow-up, and improve the use of SPG stimulation as a new
therapeutic modality for brain disorders.
Materials and Methods
All experimental procedures were approved by the Animal
Ethics Committee of Ben-Gurion University of the Negev, Beer-
Sheva, Israel. Chemicals were purchased from Sigma-Aldrich
unless otherwise stated. All images were processed by ‘‘in house’’
developed scripts (MATLAB 2009b).
Surgical Procedure
Adult male Sprague-Dawley rats, each weighing 300–400 g,
were deeply anesthetized by intraperitoneal injection of thiopen-
tal (6 mg/100 g) for the acute experiments and ketamine
(100 mg/ml, 0.08 ml/100 g) and xylazine (20 mg/ml, 0.06 ml/
100 g) for the chronic experiments. In the acute experiments
animals were tracheostomized and ventilated mechanically (SAR-
830 Ventilator), and the tail artery and vein were catheterized.
Body temperature was continuously monitored and maintained
at 3760.5uC by using a heating pad. Craniotomy was performed
as previously described [17] (1 mm caudal and 1 mm lateral to
bregma; bone window dimensions 265 mm). The dura was
removed, and the exposed cortical surface was superfused with
oxygenated (95% O2,5 %C O 2) artificial cerebrospinal fluid
(ACSF) containing (in mM) 129 NaCl, 21 NaHCO3, 1.25
NaH2PO4, 1.8 MgSO4, 1.6 CaCl2, 3 KCl, and 10 glucose
(pH 7.4).
Positioning of Stimulation Electrode
Following craniotomy, a fine bipolar hook stimulating electrode
(NeuroPath, BrainsGate) was implanted in nerve bundles, under a
surgical microscope (Zeiss OMPI 9-FC), as described previously
[9]. Briefly, scalp incision was made near the right upper orbit.
Intra-orbital structures were retracted laterally; nerve bundles,
including the nasociliary nerve and parasympathetic nerve fibers,
were separated from the SPG and a fine bipolar electrode was
placed underneath the bundle.
Induction of Stroke
Intravascular thrombosis was induced by using the photosen-
sitive dye Rose bengal (RB) [18]. Following intravenous admin-
istration of RB (7.5 mg/ml, in saline; 1.33 ml/kg body weight),
the brain was exposed to focused monochromatic laser light
(561 nm, Optoelectronic Tech lb-WL206) or halogen light (see
below) for 15 min.
Stimulation Protocol for the Acute Experiments
In these experiments, following the surgical procedure, the rat
was placed under a stereomicroscope and direct imaging of pial
vessels was performed with an EMCCD camera (Andor Tech-
nology, DL-658M-TIL). The SPG was stimulated using a
previously optimized protocol [13]: 12 stimulation trains were
administered; each train was composed of two sets of 60-s stimuli
(at 10 Hz) separated by a 12-s interval, followed by 13.6 min of
‘‘OFF’’ time, giving a total treatment time of 180 min. Three
protocols comprising different stimulation intensities and durations
were tested: a 200-ms pulse at 1 mA (n=7), a 200-ms pulse at 2 mA
(n=7), and a 500-ms pulse at 2 mA (n=7). A control group (n=6)
was exposed to the same treatments but stimulation was set at
0 mA. The most efficient pulse width determined in acute
experiments was later used for treatment in the chronic
experiments.
Stimulation Protocol for the Chronic Experiments
The effect of daily SPG stimulation on the long-term outcome
after photothrombosis was evaluated by measuring BBB perme-
ability, cortical electrical activity, lesion size and glial response.
Surgical procedures were performed as described above. Follow-
ing RB injection, the cortex was exposed to halogen light. For
chronic SPG stimulation, wireless, radio-frequency-activated
electrodes were implanted. After induction of photothrombosis,
the skin was sutured and the animals were placed in individual
cages, where they were kept for 6–21 days. Four treatment groups
were studied: (1) photothrombosis treatment without SPG
stimulation (designated RB); (2) photothrombosis with SPG
stimulation starting 15 min after treatment (RB-SPG-15 min); (3)
photothrombosis with SPG stimulation starting 24 h after
treatment (RB-SPG-24 h); and (4) control group, not exposed to
photothrombosis or stimulation (Sham). In the treated groups rats
were stimulated for four consecutive days, 3 h per day. Pulse
duration was set to 500 ms. Stimulation intensity was increased
gradually from 0.5 mA to a maximum of 2 mA (in 0.1-mA steps)
and adjusted individually for each animal until animal showed a
behavioral response (e.g. muscle twitching, startle response) to the
stimulus and then immediately reduced to a sub-clinical (asymp-
tomatic) level.
Assessment of Vascular Diameter and rCBF
For measuring vessel diameters, images were taken continuously
every 2 s, starting 1 min before stimulation. A segmentation
process using noise filtration, hole filling and an adaptive threshold
produced a binary image of the blood vessels. Within a vessel of
interest, five points were chosen manually, and an average
diameter was calculated on the basis of the number of pixels
across the vessel. Results were expressed as percent change of
baseline diameter.
To follow changes in rCBF, a laser-Doppler probe (Optronix,
OxyFlo
TM 2000) was mounted on an electrode manipulator and
placed 0.2–0.3 mm above the cortical surface [19]. rCBF
measurements were taken continuously, with flow values being
expressed in arbitrary units. In all experiments, baseline recordings
SPG Stimulation for Stroke Treatment
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were expressed as percent change relative to the baseline. In
addition, fluorescent angiography was used to estimate changes in
rCBF, as previously reported [20]. Briefly, images (30/s) were
taken following a peripheral IV injection of the fluorescent tracer
Lucifer yellow CH dipotassium salt (LY, FW=521.58). Injections
were repeated before (30 min) and during (10 min after initiation)
stimulation. Regions of interest (ROIs) in arteries and veins were
chosen manually and the intensity in each ROI was plotted as a
function of time. The peak-to-peak interval from arterial to nearby
vein and the average slope of rise (slope to max, incline) were
calculated.
Recording and Analysis of Brain Activity
Electrocorticography was performed using a telemetric system
(Data Science International, St. Paul, MN, USA). Electrodes
(Transoma Medical) were implanted through newly drilled holes
[21] in the epidural space as close as possible to the treated region
and held in place with bone-cement. The radio-telemetry pack was
inserted into a subcutaneous pocket dorsal to the scapula. ECoG
Figure 1. SPG stimulation induces vasodilation in the healthy brain A, Left and middle, respectively, representative image of the
brain surface under control conditions and during SPG stimulation: right, the same image after processing for diameter
measurement. B, Arterial (red) and venous (blue) changes in diameter (presented as % change from baseline) are shown before, during and after a
single stimulation train for the experiment shown in (A). Note that increased rCBF (gray) is following the arterial vasodilation. C, Average % change in
arterial diameter (left graph) and rCBF (right graph) during different stimulation protocols (see text). *p,0.05.
doi:10.1371/journal.pone.0039636.g001
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sampling rate of 1 kHz.
Recorded ECoG data was analyzed offline: Data was filtered
between 2–90 Hz using zero-phase forward and reverse digital
band pass filtering (filtfilt, MATLAB). The frequency spectrum
was generated using Fourier transform analysis and normalized
either for each recording session or to the first recording day of
that particular animal. The sum of the power was calculated for
the following frequency bands: 2–4, 5–10, 11-45, 46–70 and 71–
90 Hz. High amplitude (.3 SD from baseline on day 1) and fast
activity events (71–90 Hz) were defined as ‘‘seizure like events’’
and counted.
Morphology and Immunohistochemistry
BBB opening was evaluated four days after photothrombosis.
The albumin-binding dye Evans blue (EB; 1 ml of a 2% solution)
was injected into the tail veins of anesthetized animals. Thirty
minutes later, animals were perfused transcardially with 4%
paraformaldehyde (PFA, 100 ml), and their brains were removed
[17]. Images of the cortex of each animal were acquired at low
magnification (66.4) using a CCD camera (AxioCam MRc5)
under similar image acquisition settings. BBB opening was
evaluated by calculating the average intensity of the blue channel
in the treated hemisphere. The brain area with BBB opening was
calculated as the percentage of blue pixels in the treated
hemisphere vs. a fixed threshold. For morphological studies,
which were conducted 14–21 days after the induction of
photothrombosis, animals were anaesthetized and perfused with
PFA; brains were removed and stored for 48 h in PFA. Coronal
sections (40 mm thick, n=6–8) from the center of the lesion were
sliced and stained with cresyl violet (1%, 2 min) for lesion volume
measurements. Images were obtained at low magnification (66.4,
Zeiss, AxioCam MRc5). The area of the remaining cortical tissue
was measured and the loss of cortical gray matter was assessed on
the basis of the number of ipsilateral pixels representing the
neocortex in comparison with the contralateral (control) hemi-
sphere.
The glial inflammatory response was evaluated by using
immunostaining against the astrocytic marker glial fibrillary acidic
protein (GFAP) and the microglial marker ionized calcium binding
Figure 2. Fluorescent angiography during SPG stimulation A, Two representative angiographic images of cortical surface vessels
under control conditions (left) and during SPG stimulation (3 mA, 500 ms, right, white bar represents 0.1 mm). B, Intensity curves (in
arbitrary intensity units, iu) for the venous (blue) and arterial (red) compartments for the venous (blue) and arterial (red) compartments (marked in
(A)) during control injection (left) and SPG stimulation (right). C, % change in diameter (black) and peak-to-peak (arterial-venous) interval (red)a t
different stimulation intensities (1–5 mA, 500 ms).
doi:10.1371/journal.pone.0039636.g002
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40 mm were treated with 10% normal goat serum for 30 min and
incubated overnight at 4uC with polyclonal rabbit anti-GFAP
(1:250, Dako Germany) or polyclonal mouse anti-Iba1 (1:250,
Wako Pure Chemical Industries, Ltd.). For secondary antibodies,
Cy5 goat anti-rabbit IgG (1:100) and Alexa Fluor 555 goat anti-
mouse IgG (1:100, both Invitrogen Corporation) were used.
Incubation was conducted for 5 h at room temperature. Images
were acquired at 400-fold magnification (20–30 images per
section, 5–8 sections per animal) using a confocal laser-scanning
microscope (Leica TCS SP2).
Statistics
All values were expressed as means 6SEM. Statistical analysis
for differences between means comparing groups was performed
with the non-parametric Mann-Whitney Test. p values of ,0.05
were taken as significant.
Figure 3. SPG stimulation in the RB-treated cortex. A, Brain surface images in a typical experiment before (left), and after (middle)
photothrombosis and during SPG stimulation (2 mA, 500 ms, right). Note vasodilation and reperfusion of the thrombosed vessels (circled). B, Laser-
Doppler recording in the same experiment as in (A), showing reduced rCBF during photothrombosis, which was partially reversible during SPG
stimulation. C, Fluorescent angiography from a different rat before (left), after photothrombosis (middle) and during SPG stimulation (2 mA, 500 ms,
right).
doi:10.1371/journal.pone.0039636.g003
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of Evans blue indicates BBB breakdown of RB-treated (left) and RB-SPG-15 min (right) rat brains. Images below display EB (blue color)
intensity, color coded. Both the size of the area with increased EB and the intensity were decreased in SPG-treated rats compared to non-stimulated
animals (right graph). B, Immunostaining against the astrocytic marker, GFAP (upper panels) and the microglial marker, Iba-1 (lower panel) in RB-
treated (left) and the contra-lateral control hemisphere (right). Bar graphs show area measured with intracellular staining (see Methods). C, Coronal
sections of brains from RB (left) and RB-SPG-15 min (right) animals. Bar graphs show change in cortical volume after photothrombosis. *p,0.05.
doi:10.1371/journal.pone.0039636.g004
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SPG Stimulation Leads to Vasodilation and Increased
rCBF in the Healthy and Injured Brains
We first performed ‘‘acute experiments’’ to test the vascular
response to SPG stimulation. Stimulation was associated with a
slowly progressing significant dilation of pial vessels. Vasodilata-
tion was first observed in arterioles, followed by a milder dilatation
of nearby venules and was associated with increased rCBF (Fig. 1A-
B). Notably, vasodilation persisted 1–3 min after stimulation was
terminated (12.4864.3% increase in arterial diameter at 2 min
post stimulation, n=21, Fig. 1B). Diameter and rCBF increase
were dependent on the intensity and pulse width (Fig. 1C):
Stimulation at 1 mA (200 ms) did not induce a significant increase
in vascular diameter or rCBF (n=7), however stimulation at 2 mA
resulted in a significant increase in both vascular diameter and
rCBF in 12 of 14 (86%) rats. Prolonging the pulse duration to
500 ms was associated with an additional significant increase in
diameter and rCBF (Fig. 1C). No significant changes in vascular
diameter or rCBF were observed in non-stimulated animals during
3 h of recordings (n=6).
The effect of SPG stimulation on rCBF was also measured using
fluorescent angiography (Fig. 2A). During SPG stimulation,
intensity curves for the selected arteriole and venule showed a
larger incline in signal intensity and a higher maximum, indicating
increased blood flow (Fig. 2B). When the stimulation intensity was
raised from 1 to 3 mA, the arterial diameter reached its maximum;
a further increase in stimulation intensity led to a decrease in the
vascular diameter (Fig. 2C). The arterial-venous peak-to-peak
interval, an indirect measure of blood flow, generally decreased
when the stimulation intensity was increased, suggesting that
stimulation-induced vasodilatation is indeed associated with
enhanced blood flow within the affected vasculature (Fig. 2B). In
these experiments, stimulus-induced vasodilation and elevation of
blood flow were not associated with a significant increase in BBB
permeability measured using fluorescent angiography [20] (data
not shown and see below).
In the RB-treated cortex fluorescent angiography and laser-
Doppler flowmetry confirmed the induction of intravascular
thrombosis and the associated reduced blood flow within the
injured vessels (Fig. 3A-B). In three of four RB-treated rats, SPG
stimulation 5–15 min after the induction of photothrombosis
induced partial recovery of rCBF, as measured using laser Doppler
flowmetry. Notably, vasodilation of thrombosed vessels was
evident, while fluorescent angiography confirmed partial reperfu-
sion of the injured cortex (Fig. 3).
SPG Stimulation in RB-Treated Animals Protects BBB
Integrity and Reduces the Volume of Necrotic Cell Loss
Vascular dysfunction with a leaky BBB is a hallmark of the peri-
ischemic region [23]. We thus tested the effect of SPG stimulation
on BBB opening in the RB model. Consistent with previous studies
[24], a large region of the cortex surrounding the photothrombotic
lesion showed intraparenchymal staining with an EB-albumin
complex, indicating BBB dysfunction (Fig. 4A). In SPG-stimulated
rats (n=6), both the size of the stained cortical region and the
intensity of the dye were smaller compared to those in RB-treated
non-stimulated animals (n=6, Fig. 4A). The peri-infarct zone was
also associated with activation of astrocytes and microglia, as seen
by enhanced immunostaining for GFAP and Iba-1, respectively
(Fig. 4B). No differences in astrocytic or microglia stainings within
the peri-infarct zone were found between SPG-stimulated and
non-stimulated controls (Fig. 4B).
To measure the volume of brain loss following RB-induced
ischemia, cortical volume was measured in the ipsilateral vs. the
contralateral hemisphere two-three weeks after treatment (Fig. 4C,
left). Importantly, rats stimulated either at 15 min or 24 h after
photothrombosis showed a significant reduction in loss of brain
tissue compared to non-treated controls (37.166.0; 20.664.8 and
17.965.1% reduction in cortical volume compared to the
contralateral hemisphere for RB, n=9; RB-SPG-15 min, n=8
and RB-SPG-24 h, n=6, respectively, Fig. 4C).
SPG Stimulation in RB-Treated Animals Improves Cortical
Functions
Since BBB dysfunction has been shown to lead to cortical
dysfunction and seizures [25,26], we used epidural electrodes
placed above the peri-ischemic region to record ECoG network
activity for six days after the induction of stroke (RB (n=10), RB-
SPG-15 min (n=9), RB-SPG-24 h (n=9)).
Another group of animals (n=8) were exposed to the same
surgical procedures but without photothrombosis (sham). Differ-
ences in ECoG activity were measured using power spectrum
analysis and compared between the groups (Fig. 5A). Normalized
power in the low frequency range (,10 Hz) was decreased and in
the high frequency range (.60 Hz) was increased over RB-treated
cortices (Fig. 5A). Changes in power became significant from day 4
after photothrombosis and were most prominent in the 5–10 Hz
and 46–90 Hz frequency bands. Importantly, SPG stimulation
resulted in normalization of cortical activity, and both early
(15 min)-treated and late (24 h)-treated groups showed ECoG
activity similar to that of the sham group. The increased power in
the high frequency range was due to the appearance of high
amplitude, fast, seizure-like events in RB-treated animals but only
rarely in controls (Fig. 5B). Indeed, the total time ECoG displayed
high amplitude fast activity was significantly increased in the RB-
treated group compared to sham controls or SPG-treated animals
(Fig. 5C-D).
Discussion
In the present study, we examined – for the first time– the effect
of SPG stimulation on the diameter and blood flow in surface
cortical vessels in healthy and ischemic brains. We further tested
the effect of repetitive SPG stimulation on cortical electrophysi-
ology within the peri-infarct region in the photothrombosis model.
The main findings of this study were: (1) SPG stimulation led to
intensity- and pulse width dependent vasodilation and increased
rCBF; (2) SPG-induced vasodilation facilitated partial reperfusion
of occluded vessels in the phothrombosis RB model; (3) the peri-
ischemic zone showed increased permeability of the BBB, which
was reduced in size both immediate and delayed stimulation of the
SPG; (4) the necrotic core lesion was smaller following SPG
treatment; (5) fast cortical electrical activity and seizure-like events
were prominent from day 3 after photothrombosis and reduced to
control levels in SPG treated animals.
This is the first study to show - using high-resolution direct
imaging - a stimulation-induced significant and preferential
vasodilation of cortical arterioles. Our findings confirm that in
SPG stimulation, vasodilation is dependent on the stimulation
intensity and pulse width (Fig. 1) within a narrow range of
stimulation parameters (1–3 mA, 0.1–0.5 ms). It is of note that
rCBF measurements by laser Doppler flowmeter or fluorescent
angiography similarly showed 10–30% increase in the diameter of
superficial arterioles and .100% increase in rCBF when
stimulated at moderate-high (.1 mA) intensities. These results
are consistent with previous studies showing 40–100% increase in
SPG Stimulation for Stroke Treatment
PLoS ONE | www.plosone.org 7 June 2012 | Volume 7 | Issue 6 | e39636Figure 5. ECoG Fast Fourier Analysis: A, Averaged power of the normalized ECoG 1-3 (left) and 4–6 (right) days after
photothrombosis in low and high frequency ranges (note the different right and left Y axis). B, Typical ECoG recordings of RB-treated
(left) and sham animals (right). C, ECoG recording after high pass filter (71–90 Hz) of RB-treated (lower trace) and sham animals (upper trace). D,
Duration of fast activity (sec/h) for the different treated groups. Symbols as in (A). *p,0.05.
doi:10.1371/journal.pone.0039636.g005
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[27] or MRI perfusion [15,28] and 10–40% increase in the
diameter of the larger arterial brain suppliers in a dog model for
sub-arachnoid hemorrhage [13]. A milder effect on rCBF was
reported by Henninger and Fisher [15] in rats, when isoflurane
anesthesia was used, perhaps because of the vasodilating effect of
isoflurane [29]. While previous studies in monkeys demonstrated
that SPG stimulation induces dilatation of constricted large vessels
(internal carotid, anterior cerebral and middle cerebral arteries), in
a sub-arachnoid hemorrhage model [30], our study shows that
similar dilation occurs in small surface arterioles (but not venules)
of the healthy brain. Recently, similar protocol has been shown to
increase perfusion in MRI scans of rats following MCAO
occlusion [28], suggesting that the vasodilation we observed in
superficial vessels reflects a general response of both superficial and
deep vessels to stimulation of the parasympathetic fibers of the
greater superficial petrosal nerves [31].
Notably, using the direct imaging approach [20] we show for
the first time in a stroke (photothrombosis) model, that SPG-
induced vasodilation may result in immediate reperfusion of the
ischemic core. Reperfusion was not associated with any apparent
‘‘steeling effect’’, as indicated by laser Doppler recordings and
angiography, documenting stimulation-mediated increase in per-
fusion of the peri-ischemic region as well (Fig. 3 and see below).
Since SPG stimulation has been suggested to increase BBB
permeability in the healthy and injured brain [13], and since
stroke is often associated with BBB dysfunction, we evaluated the
effect of stimulation on vascular permeability in the peri-ischemic
brain. In contrast to previous studies [14,32], SPG-induced
stimulation protocols in the present study did not induce a
significant increase in BBB permeability within the healthy brain.
This could be attributed to the low intensity, short duration
(,0.5 ms in our study vs. .1 ms in [32]), clinically tolerable
stimulation applied, to the more focal stimulation method (bipolar
stimulation in our study vs. monoplar stimulation in [32]) or to the
avoidance of isoflurane anesthesia, which may contribute to BBB
breakdown [33]. For the first time, we tested the delayed effect of
SPG stimulation on vascular permeability in a rat stroke model.
Remarkably, 24 h following photothrombosis, both the intensity
and the extent of the area showing EB extravasation were
significantly reduced in the SPG-treated group compered to RB
group, indicating a reduction in BBB damage within the peri-
ischemic region. The protective effect of SPG stimulation on BBB
breakdown may be due to reperfusion of the ischemic core and
reduced cellular damage and/or due to increased rCBF in the
peri-ischemic brain itself. Since BBB breakdown induces a rapid
inflammatory response [34] and activation of astrocytes [22,35] we
searched for differences in the immune-labeling of reactive
microglia and astrocytes between the RB-treated groups. While
no differences were found between the groups in the peri-ischemic
region, we cannot exclude milder differences below the sensitivity
of our detection methods, or functional differences in glial
properties. Indeed, in consistent with recent studies demonstrating
the role of BBB dysfunction and the associated astroglial response
in the generation of seizures and delayed neuronal damage
[4,26,36,37], our ECoG recordings from the peri-ischemic, BBB
dysfunctional cortex confirmed a gradual increase in the
occurrence of seconds-long, fast and high amplitude, seizure-like
events within the first week after photothrombosis. SPG stimula-
tion and the subsequent milder BBB dysfunction were associated
with normalization of brain activity and reduced occurrence of the
seizure-like events. The decreased loss of brain tissue measured 2–
3 weeks after treatment could result from the stimulus-induced
vasodilation and increased oxygen supply to the ischemic core, but
may also be directly related to the increased perfusion and
decreased vascular (BBB) damage in the peri-ischemic brain.
Future studies are required to reveal whether BBB dysfunction is
directly related to stroke progression (due, for example, to the
leakage of serum components into the brain tissue) or is simply a
bystander biomarker for vascular pathology. Since ischemic
damage in the core region is expected to become irreversible
within few hours after the reduction of perfusion, it is tempting to
speculate that the salvage of brain tissue in the 24 h post-insult
stimulation protocol indicates that vascular damage around the
ischemic core underlies stroke progression. This allows a beneficial
effect for increased perfusion, even when initiated 24 h after the
primary insult (Fig. 6). Accelerating BBB repair in the peri-
Figure 6. A working hypothesis on SPG-induced brain protec-
tion after stroke: The ischemic core is surrounded by a peri-
ischemic region which is susceptible for an irreversible injury
(AKA ‘‘stroke progression’’). The peri-ischemic lesion is character-
ized by dysfunction of the blood-brain barrier (BBB) which induces
neuronal hyper-excitability, spreading depolarizations and seizures,
inflammation and cellular damage [4]. SPG stimulation at an early, post-
insult therapeutic time window induces vasodilation and increased
rCBF, sufficient to re-perfuse the ischemic core and to reduce lesion
size. When stimulation is initiated at a delayed post-insult therapeutic
window (24 h), vasodilation in the peri-ischemic lesion attenuates BBB
injury and the associated neuronal hyper-excitability, thus preventing
progression of the primary lesion.
doi:10.1371/journal.pone.0039636.g006
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hemorrhagic transformation [38]. Furthermore, if this hypothesis
is valid, BBB damage in the peri-ischemic brain may serve as a
biomarker for predicting the efficacy of delayed treatment. The
benefit of 24 h stimulation protocol is consistent with a recent
study showing ameliorate MRI tissue characteristics in the rat
MCAO model even when SPG has been started 18 h post-
occlusion [28]. Treatment efficacy is emphasized in our study by
the complete normalization of brain activity and the observed
reduction of lesion size. Normalization of hyper-excitability in the
peri-ischemic brain might be related to amelioration of blood flow
and/or vessels’ integrity. While behavioral studies are awaited to
confirm the functional and anatomical study performed here, the
clinical implications of our results are emphasized by recent
recordings in human patients following stroke or sub-arachnoid
hemorrhage showing high frequency of seizures and spreading
depolarizations within the peri-lesional brain and their potential
role in delayed damage [39–42]. Together, these findings stress the
potential of brain activity monitoring in stroke for diagnosis and
treatment decisions and suggest a longer therapeutic window in
selected patients.
In conclusion, this study shows that SPG-stimulation in rats,
even 24 h after the induction of photothrombosis, improves
cortical functions and reduces the extent of early BBB dysfunction
as well as the size of the necrotic region. These results further
strengthen the prevailing notion that SPG therapy may have a
beneficial role in the treatment of stroke and emphasize potential
mechanisms underlying the effects of SPG stimulation on peri-
ischemic brain areas.
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